Want a Lifetime of Passive Income? Buy Altria Stock in July and Never Sell.

Altria highlights a 5.8% forward dividend yield versus a 4.6% 10-year Treasury and says it used only 81% of free cash flow on dividends over the past 12 months, framing payouts as sustainable. The article cites dividend growth consistency (Dividend King with 60 raises over 56 years), an expected 13% EPS CAGR from 2025–2028, and a target of at least $5B in smoke-free revenue by 2028 to offset declining cigarette volumes. It also points to ongoing buybacks (9% over five years) and potential upside from FDA actions on smaller alternative nicotine products, suggesting the stock is valued at about 13x this year’s earnings.

Analysis

This is less an earnings-revision story than a capital-allocation story: MO screens like a leveraged bond proxy with an embedded call option on regulatory consolidation. At a ~5.8% yield, the stock only has room to rerate if the market starts believing the payout is both durable and growing faster than inflation; otherwise most of the return will continue to come from carry and buybacks, not organic growth.

The real second-order effect is competitive filtration. If enforcement tightens around smaller nicotine alternatives, MO’s scale, distribution, and legal shelf access matter more than its brand portfolio; that would pressure fragmented vape and pouch players first, then flow through convenience-store shelf share over several quarters. But the “2028 smoke-free mix” narrative is long-dated and not a near-term catalyst unless next two earnings prints show accelerating on! / NJOY throughput rather than just price-led EPS.

The risk is that investors treat this like a safe income stock while ignoring how little of the upside is under management control. Cigarette pricing can offset volume declines for a while, but if rate cuts do not arrive or the FDA moves slower than expected, the multiple can stay capped in the low-teens and the dividend becomes the whole investment case. Contrarian view: the market may be underestimating the durability of cash returns, but it is not overpricing the secular decline; this is attractive on pullbacks, not as a fresh momentum buy.

Key Decisions for Investors

• Long MO only as a defensive income carry, preferably on a 3-5% pullback; use a 3-6 month horizon and take profits if the stock rerates materially above the low-teens forward multiple because upside is mostly yield-driven.
• Sell cash-secured puts on MO 5-10% below spot for the next 1-2 quarters to monetize rich carry and muted volatility; this works best if rates stay elevated and the stock remains range-bound.
• Watch-list, not buy-list: add MO only if the next 1-2 earnings reports show actual smoke-free share gains and not just pricing; falsifier is any guidance cut tied to faster cigarette volume erosion or weaker buyback capacity.